Health

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma

DailyTrendDailyTrend
Apr 15, 2025 - 17:00
 0  3
FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma
PRINCETON, N.J.--(BUSINESS WIRE) April 11, 2025 -- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a first-line treatment for adult...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

FDA Approves Apellis’ Empaveli (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older

FDA Approves Apellis’ Empaveli (pegcetacoplan) as the F...

DailyTrend Jul 30, 2025  0  0

FDA Approves Alhemo as Once-Daily Prophylactic Treatment to Prevent or Reduce the Frequency of Bleeding Episodes for Adults and Children 12 Years of Age and Older with Hemophilia A or B (HA/HB) Without Inhibitors

FDA Approves Alhemo as Once-Daily Prophylactic Treatmen...

DailyTrend Aug 3, 2025  0  0

Trump Announces Health Care Records System for Consumers

Trump Announces Health Care Records System for Consumers

DailyTrend Jul 31, 2025  0  0

Morton Mintz, Muckraking Crusader for Consumers, Dies a...

DailyTrend Jul 30, 2025  0  0

Top F.D.A. Official Resigns Under Pressure

Top F.D.A. Official Resigns Under Pressure

DailyTrend Jul 30, 2025  0  0

FDA Approves Vizz (aceclidine ophthalmic solution) for the Treatment of Presbyopia

FDA Approves Vizz (aceclidine ophthalmic solution) for ...

DailyTrend Aug 4, 2025  0  0